Category Archives: Access to Medecines

On Announcement of All Oral MDR TB regimen by Indian Government

26th Sep 2019, New Delhi On 25 September Wednesday, at the event- TB Harega Desh Jitega organised in New Delhi, the Central TB programme announced the rolling out an all oral Multi Drug Resistant TB regimen across the country starting … Continue reading

Posted in Access to Medecines, Drugs, Multi-Drug Resistant Bacteria | Leave a comment

SCP 30: General statement of Knowledge Ecology International

Source: KEI 26th June, 2019   On Monday, 24 June 2019, Knowledge Ecology International (KEI) delivered this opening statement at WIPO’s 30th Session of the Standing Committee on the Law of Patents (SCP). The Committee elected a new chair, Sarah Whitehead, … Continue reading

Posted in Access to Medecines, IPR, Transparency | Leave a comment

Human Rights Council (2019): Core Group circulates zero draft on access to medicines and vaccines

Source: KEI 26th June, 2019   At the 41st session (24 June 2019 – 12 July 2019) of the Human Rights Council, a bloc of countries known as the the Core Group (Brazil, Egypt, Indonesia, India, Senegal, South Africa and Thailand) … Continue reading

Posted in Access to Medecines, IP Rights, Transparency | Leave a comment

Public Health-Driven R&D Focus Of Draft HRC Resolution On Access To Medicines & Vaccines

Source: Health Policy Watch 25th June, 2019   A United Nations Human Rights Council (HRC) draft resolution on access to medicines and vaccines calls for making public health needs more central to the research and development (R&D) of new health products, … Continue reading

Posted in Access to Medecines | Leave a comment

WHA72: Portuguese Minister of Health, Marta Temido, underscores strong support for the WHO transparency resolution

Source: Keionline 22nd May, 2019   On Monday, 20 May 2019, the Republic of Korea, Italy, Costa Rica, Greece, Indonesia, Italy, Mexico, Mongolia, Netherlands, Portugal, Republic of Korea, Saudi Arabia, Spain, and Vietnam convened an official side event at the 72nd … Continue reading

Posted in Access to Medecines, IP Rights, Transparency | Leave a comment

Withdrawal Of GSP By the US is India’s Opportunity to End Loot By Big Pharma

Source : Newsclick 14 march,2019,New Delhi Now, there is all the more reason for the government to place peoples’ health above the trade interests and impose price control on all the medical devices notified as drugs under the Drugs and … Continue reading

Posted in Access to Medecines | Leave a comment

Using compulsory licence for affordable medicines

Source: Astro Awani 14 March,2019,New Delhi RECENTLY, Malaysia made headlines again for its “government use” compulsory license (CL) to gain access to a generic version of a Hepatitis C medicine called Sofosbuvir.Malaysia has been facing pressure from pharmaceutical companies and … Continue reading

Posted in Access to Medecines | Leave a comment